US Stock MarketDetailed Quotes

INZY Inozyme Pharma

Watchlist
  • 0.920
  • -0.075-7.49%
Close Mar 28 16:00 ET
  • 0.966
  • +0.046+5.00%
Post 18:24 ET
59.11MMarket Cap-0.57P/E (TTM)

Inozyme Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
37.52%104.03M
19.13%27.17M
37.50%24.85M
68.75%27.67M
32.53%24.35M
10.15%75.65M
16.77%22.81M
6.87%18.07M
6.52%16.39M
9.09%18.37M
Selling and administrative expenses
0.00%20.8M
-2.63%4.7M
4.82%4.96M
24.94%5.91M
-19.63%5.23M
-0.13%20.8M
-15.29%4.83M
0.25%4.73M
-12.18%4.73M
29.59%6.51M
-General and administrative expense
0.00%20.8M
-2.63%4.7M
4.82%4.96M
24.94%5.91M
-19.63%5.23M
-0.13%20.8M
-15.29%4.83M
0.25%4.73M
-12.18%4.73M
29.59%6.51M
Research and development costs
51.75%83.23M
24.97%22.47M
49.09%19.89M
86.51%21.76M
61.18%19.11M
14.63%54.85M
29.96%17.98M
9.43%13.34M
16.58%11.67M
0.36%11.86M
Operating profit
-37.52%-104.03M
-19.13%-27.17M
-37.50%-24.85M
-68.75%-27.67M
-32.53%-24.35M
-10.15%-75.65M
-16.77%-22.81M
-6.87%-18.07M
-6.52%-16.39M
-9.09%-18.37M
Net non-operating interest income expense
-53.20%2.11M
-95.04%62K
-74.44%362K
-24.31%635K
5.01%1.05M
133.01%4.5M
53.37%1.25M
92.13%1.42M
161.37%839K
1,565.00%999K
Non-operating interest income
-2.18%7.67M
-41.37%1.48M
-24.95%1.78M
26.09%2.03M
78.90%2.37M
257.04%7.84M
135.00%2.53M
221.44%2.37M
401.56%1.61M
2,111.67%1.33M
Non-operating interest expense
66.76%5.56M
11.01%1.42M
48.58%1.42M
80.93%1.4M
303.96%1.33M
1,172.14%3.33M
--1.28M
--953K
--771K
--328K
Other net income (expense)
-264.29%-102K
150.00%35K
-505.00%-81K
89.29%-3K
-50.00%-51K
91.22%-28K
-91.95%14K
110.15%20K
85.34%-28K
67.62%-34K
Other non- operating income (expenses)
-264.29%-102K
150.00%35K
-505.00%-81K
89.29%-3K
-50.00%-51K
91.22%-28K
-91.95%14K
110.15%20K
85.34%-28K
67.62%-34K
Income before tax
-43.35%-102.02M
-25.67%-27.07M
-47.67%-24.57M
-73.48%-27.03M
-34.15%-23.35M
-6.13%-71.17M
-16.18%-21.54M
-1.62%-16.64M
-2.11%-15.58M
-3.08%-17.4M
Income tax
Net income
-43.35%-102.02M
-25.67%-27.07M
-47.67%-24.57M
-73.48%-27.03M
-34.15%-23.35M
-6.13%-71.17M
-16.18%-21.54M
-1.62%-16.64M
-2.11%-15.58M
-3.08%-17.4M
Net income continuous Operations
-43.35%-102.02M
-25.67%-27.07M
-47.67%-24.57M
-73.48%-27.03M
-34.15%-23.35M
-6.13%-71.17M
-16.18%-21.54M
-1.62%-16.64M
-2.11%-15.58M
-3.08%-17.4M
Minority interest income
Net income attributable to the parent company
-43.35%-102.02M
-25.67%-27.07M
-47.67%-24.57M
-73.48%-27.03M
-34.15%-23.35M
-6.13%-71.17M
-16.18%-21.54M
-1.62%-16.64M
-2.11%-15.58M
-3.08%-17.4M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-43.35%-102.02M
-25.67%-27.07M
-47.67%-24.57M
-73.48%-27.03M
-34.15%-23.35M
-6.13%-71.17M
-16.18%-21.54M
-1.62%-16.64M
-2.11%-15.58M
-3.08%-17.4M
Basic earnings per share
-18.25%-1.62
-20.00%-0.42
-34.48%-0.39
-25.71%-0.44
5.00%-0.38
23.03%-1.37
16.67%-0.35
23.68%-0.29
7.89%-0.35
43.66%-0.4
Diluted earnings per share
-18.25%-1.62
-20.00%-0.42
-34.48%-0.39
-25.71%-0.44
5.00%-0.38
23.03%-1.37
16.67%-0.35
23.68%-0.29
7.89%-0.35
43.66%-0.4
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 37.52%104.03M19.13%27.17M37.50%24.85M68.75%27.67M32.53%24.35M10.15%75.65M16.77%22.81M6.87%18.07M6.52%16.39M9.09%18.37M
Selling and administrative expenses 0.00%20.8M-2.63%4.7M4.82%4.96M24.94%5.91M-19.63%5.23M-0.13%20.8M-15.29%4.83M0.25%4.73M-12.18%4.73M29.59%6.51M
-General and administrative expense 0.00%20.8M-2.63%4.7M4.82%4.96M24.94%5.91M-19.63%5.23M-0.13%20.8M-15.29%4.83M0.25%4.73M-12.18%4.73M29.59%6.51M
Research and development costs 51.75%83.23M24.97%22.47M49.09%19.89M86.51%21.76M61.18%19.11M14.63%54.85M29.96%17.98M9.43%13.34M16.58%11.67M0.36%11.86M
Operating profit -37.52%-104.03M-19.13%-27.17M-37.50%-24.85M-68.75%-27.67M-32.53%-24.35M-10.15%-75.65M-16.77%-22.81M-6.87%-18.07M-6.52%-16.39M-9.09%-18.37M
Net non-operating interest income expense -53.20%2.11M-95.04%62K-74.44%362K-24.31%635K5.01%1.05M133.01%4.5M53.37%1.25M92.13%1.42M161.37%839K1,565.00%999K
Non-operating interest income -2.18%7.67M-41.37%1.48M-24.95%1.78M26.09%2.03M78.90%2.37M257.04%7.84M135.00%2.53M221.44%2.37M401.56%1.61M2,111.67%1.33M
Non-operating interest expense 66.76%5.56M11.01%1.42M48.58%1.42M80.93%1.4M303.96%1.33M1,172.14%3.33M--1.28M--953K--771K--328K
Other net income (expense) -264.29%-102K150.00%35K-505.00%-81K89.29%-3K-50.00%-51K91.22%-28K-91.95%14K110.15%20K85.34%-28K67.62%-34K
Other non- operating income (expenses) -264.29%-102K150.00%35K-505.00%-81K89.29%-3K-50.00%-51K91.22%-28K-91.95%14K110.15%20K85.34%-28K67.62%-34K
Income before tax -43.35%-102.02M-25.67%-27.07M-47.67%-24.57M-73.48%-27.03M-34.15%-23.35M-6.13%-71.17M-16.18%-21.54M-1.62%-16.64M-2.11%-15.58M-3.08%-17.4M
Income tax
Net income -43.35%-102.02M-25.67%-27.07M-47.67%-24.57M-73.48%-27.03M-34.15%-23.35M-6.13%-71.17M-16.18%-21.54M-1.62%-16.64M-2.11%-15.58M-3.08%-17.4M
Net income continuous Operations -43.35%-102.02M-25.67%-27.07M-47.67%-24.57M-73.48%-27.03M-34.15%-23.35M-6.13%-71.17M-16.18%-21.54M-1.62%-16.64M-2.11%-15.58M-3.08%-17.4M
Minority interest income
Net income attributable to the parent company -43.35%-102.02M-25.67%-27.07M-47.67%-24.57M-73.48%-27.03M-34.15%-23.35M-6.13%-71.17M-16.18%-21.54M-1.62%-16.64M-2.11%-15.58M-3.08%-17.4M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -43.35%-102.02M-25.67%-27.07M-47.67%-24.57M-73.48%-27.03M-34.15%-23.35M-6.13%-71.17M-16.18%-21.54M-1.62%-16.64M-2.11%-15.58M-3.08%-17.4M
Basic earnings per share -18.25%-1.62-20.00%-0.42-34.48%-0.39-25.71%-0.445.00%-0.3823.03%-1.3716.67%-0.3523.68%-0.297.89%-0.3543.66%-0.4
Diluted earnings per share -18.25%-1.62-20.00%-0.42-34.48%-0.39-25.71%-0.445.00%-0.3823.03%-1.3716.67%-0.3523.68%-0.297.89%-0.3543.66%-0.4
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--------

Market Insights

U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Abits
ABTS
3.277
Digihost Technology
DGHI
1.320
Ebang International
EBON
4.0500
4
BIT Mining
BTCM
1.790
5
Canaan
CAN
0.911
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call
Monetary Policy: Navigating the Fed's Rate Cut Cycle
Changing Fed policy is altering the market math for investors.